Description: |
CNX-1351 is a selective covalent Inhibitor of PI3Kα. CNX-1351 was tested against all four of the class I PI3K enzymes α, β, γ, and δ. In an end point assay, CNX-1351 potently inhibited PI3Kα and was 20−400 times less potent against β, γ, and δ. CNX-1351 inhibit PI3Kα signaling in cells and shows prolonged inhibition consistent with a covalent mechanism of Action. CNX-1351 inhibits growth of cells dependent on PI3Kα. CNX-1351 also inhibits PI3Kα signaling in vivo and bonds to p110α.For the detailed information of CNX-1351, the solubility of CNX-1351 in water, the solubility of CNX-1351 in DMSO, the solubility of CNX-1351 in PBS buffer, the animal experiment (test) of CNX-1351, the cell expriment (test) of CNX-1351, the in vivo, in vitro and clinical trial test of CNX-1351, the EC50, IC50,and Affinity of CNX-1351, Please contact DC Chemicals. |